PATH
Seattle, Washington, United States
Purpose
To maintain the IND of a lyophilized stock of Shigella sonnei 53G strain to be used in human challenge studies for the advancement of Shigella vaccines for global health use.
Division
Global Health
Date
July 2024
Region Served
GLOBAL
Committed amount
$65,845
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
35
Grantee location
Seattle, Washington, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.